LOGIN  |  REGISTER
Assertio
Terns Pharmaceuticals

Ambetter Health Expands Health Insurance Offering into Iowa in 2024

October 02, 2024 | Last Trade: US$63.52 1.74 2.82
  • Iowa residents will have access to a variety of affordable plans from Ambetter Health during open enrollment beginning Nov. 1

DES MOINES, Iowa, Oct. 2, 2024 /PRNewswire/ -- Ambetter Health, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will now offer Iowans a variety of affordable health insurance plans to residents in 33 counties in Iowa in 2025. Open enrollment for the Health Insurance Marketplace for Iowa runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15 for coverage starting Jan. 1, 2025.   

"With Ambetter Health, we've designed a variety of coverage options to help individuals access viable health solutions designed to meet their unique needs," said Mitch Wasden, Plan President & CEO of Iowa Total Care. "Our commitment is not just to provide high-quality insurance, but to build a healthier Iowa for all, where every member feels valued, supported and equipped to thrive."

Ambetter Health offers its members access to quality care, convenient services and valuable rewards. The 2025 benefits and offerings include:

  • Affordable and Reliable Coverage
    Ambetter Health provides coverage for all essential health benefits, including preventive and wellness services, maternity and newborn care, pediatric services, mental health services, hospitalizations and prescription drug coverage. Some plans also include dental and vision coverage.
  • Virtual 24/7 Care
    Virtual 24/7 Care offers members an Ambetter-designated licensed provider via telehealth for members to access care for illnesses such as flu, skin conditions, ear infections, fever and respiratory infections – all from the comfort of their own home.

  • Convenient Online Enrollment
    Through the Ambetter Health website, people can browse and compare coverage options, determine their eligibility for financial subsidies and directly enroll in coverage – all in one place. The platform is accessible through mobile devices, so people can enroll using smartphones. If a person is unable to complete enrollment all at once, the system will save progress and provide reminders to finish enrollment.

Below is a full list of the counties in which Ambetter Health will be offered in 2025:

  • Benton
  • Buchanan
  • Cedar
  • Cerro Gordo
  • Cherokee
  • Chickasaw
  • Clinton
  • Crawford
  • Dubuque
  • Floyd
  • Fremont
  • Hancock
  • Hardin
  • Henry
  • Ida
  • Jackson
  • Jefferson
  • Kossuth
  • Lee
  • Linn
  • Louisa
  • Mahaska
  • Mills
  • Monona
  • Monroe
  • Montgomery
  • Pottawattamie
  • Ringgold
  • Shelby
  • Sioux
  • Van Buren
  • Washington
  • Woodbury

Iowa residents interested in learning more about Ambetter Health or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/ia

About Ambetter Health

Ambetter Health serves under-insured and uninsured populations through the federal Health Insurance Marketplace. Ambetter Health is underwritten by Iowa Total Care, Inc., which is a Qualified Health Plan issuer in Iowa. For more information, please visit ambetterhealth.com/en/ia/. This is a solicitation for insurance. For information on your right to receive an Ambetter Health plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB